About Triton BioPharma
The majority of our drugs for infectious diseases and cancer are natural products based on terrestrial plants and soil microbes, or at least their prototype is of natural origin. The focus of Triton BioPharma AG's activities is on harnessing the immense resources of the sea to develop next-generation therapeutics. The structural and biological diversity of the oceans offers a rich treasure trove of novel drug candidates and drug-like molecules for commercial development. With the production of marine-associated fine chemicals and pharmaceutical products, Triton is able to offer innovative products to the pharmaceutical, food and biotechnology sectors by leveraging these resources. In addition to its drug candidates in preclinical development, Triton AG has an inventory of unique marine-derived natural products available for purchase.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Pharma
